REFERENCES
- Khajavi M, Inoue K, Lupski JR. Nonsense-mediated mRNA decay modulates clinical outcome of genetic disease. Eur J Hum Genet. 2006;14(10):1074–1081.
- Giardine B, van Baal S, Kaimakis P, et al. HbVar database of human hemoglobin variants and thalassemia mutations: 2007 update. Hum Mutat. 2007;28(2):206 (http://globin.cse.psu.edu).
- Frischknecht H, Dutly F. A 65 bp duplication/insertion in exon II of the β globin gene causing β0-thalassemia. Haematologica. 2007;92(3):423–424.
- Vella F. Variation in Hemoglobin A2. Hemoglobin. 1977;1(7):619–650.
- Phylipsen M, Gallivan MV, Arkesteijn SG, Harteveld CL, Giordano PC. Occurrence of common and rare δ-globin gene defects in two multiethnic populations: thirteen new mutations and the significance of δ-globin gene defects in β-thalassemia diagnostics. Int J Lab Hematol. 2011; 33(1):85–91.
- Huisman THJ, Punt K, Schaad JDG. Thalassemia minor associated with Haemoglobin-B2 heterozygosity. A family report. Blood. 1961;17(6):747–757.
- Codrington JF, Li H-W, Kutlar F, Gu L-H, Ramachandran M, Huisman THJ. Observation on the levels of Hb A2 in patients with different β-thalassemia mutations and a δ chain variant. Blood. 1990;76(6):1246–1249.
- Vermeersch P, Philippe M, Goossens W. Co-inheritance of Haemoglobin A2′ and β-thalassaemia in cis. Int J Lab Hematol. 2008;30(4):334–338.
- Waye JS, Patterson M, Walker L, . β-Thalassemia in association with a new δ-chain hemoglobin variant [δ116(G18)Arg→Leu]: Implications for carrier screening and prenatal diagnosis. Am J Hematol. 2003;74(3):179–181.